Boston, USA-based biotech Antares Therapeutics, launched yesterday with $177 million in Series A financing. Antares is a spin ...

Insmed earlier announced positive top-line results from its randomized, double-blind, placebo-controlled Phase IIb study of ...

The company's ability to integrate reagents, instruments, and services into a unified platform drew significant attention from pharmaceutical and biotech ... types of products and services to ...

Texas Lt. Gov. Dan Patrick said he thinks he “knows where his heart is,” referring to Gov. Greg Abbott’s pending decision on ...

SAN DIEGO, June 11, 2025--iXCells Biotechnologies USA, Inc. ("iXCells"), a leading cell technology company specializing in ...

Our grandparents paid taxes that support our prosperity today. It's critical that we step up for our kids and their kids.

The Phase 1 dose escalation has been completed, and results show encouraging early signs of clinical activity in solid tumors ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the "Company") today announced that its TROP2-directed antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) (佳泰莱 ®) in combination with ...

Korean pharmaceutical and biotechnology companies are gearing up for a strong presence at the 2025 BIO International ...

Freshwater Microalgae Market Rising interest in eco-friendly products and advancements in microalgae cultivation technologies are driving m ...